New formulation allows twice-daily dosing in patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate, or sickle cell disease or other anemias. BOSTON, March 31, 2023 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of…
News Ticker
- [ December 6, 2023 ] AbbVie makes another local multibillion-dollar buy with Cerevel acquisition News
- [ December 6, 2023 ] Operations Product Leader III – Thermo Fisher Scientific – Cambridge, MA Jobs
- [ December 6, 2023 ] Principal Scientist, Cell Culture MS&T – Bristol Myers Squibb – Devens, MA Jobs
- [ December 6, 2023 ] Principal Associate Scientist – RNA – Ginkgo Bioworks Inc. – Boston, MA Jobs
- [ December 6, 2023 ] Healey administration pursues new blueprint for a dominant AI sector: ‘AI for X’ News
Copyright © 2023 Biotech Networks, LLC
